The lab
I worked with Bhasin Labs at Harvard Medical School and Beth Israel Deaconess Medical Center in Boston. The work is computational: take sequencing data from a lab bench and work out which genes a disease, or a treatment, switches on and off.
That evidence comes first. Before a treatment can be tried in people, someone has to show what it does at the level of genes and pathways, and that is what a paper is built on.
The questions
Three studies were running that summer.
- Does Withania somnifera, the herb better known as ashwagandha, do anything measurable against colon cancer?
- What can the human gut microbiome and digestive system tell us that helps antibiotic development?
- Could a rheumatoid arthritis medication be used to treat systemic lupus?
What I did
- Gene expression. Analysed RNA sequencing data from rat colon cells, 36,000 genes per cell, comparing expression with heat maps and box plots.
- Pathways. Ran Ingenuity Pathway Analysis to see which biological pathways the changes in expression pointed to.
- Efficacy. Used R to compare how tumour cells grew against how they were predicted to grow, to judge whether the herb was having an effect.
- Microbiome. Investigated the human gut microbiome and digestive system in support of antibiotic development.
- Figures. Built the visual data representations for a research paper on applying a rheumatoid arthritis medication to systemic lupus.
From sequencer to figure
- RNA sequencing
- Expression for 36,000 genes
- Statistics in R
- Heat maps and box plots
- Pathway analysis
What came of it
- 36,000
genes per cell analysed in the colon cancer study.
- 3
studies worked on: colon cancer, the gut microbiome and lupus.
- 1
research paper’s figures built.